Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Fusionopolis Stories

2014-04-08 00:21:41

SINGAPORE, April 8, 2014 /PRNewswire/ -- NMC officially opened its liquid flow metrology lab to strengthen measurement quality for key industries. NMC also announced an RCA with Mogas Flow Lab (MFL) to establish a R&D lab to develop bunker fuel-based Primary Liquid Flow Standard and a Heavy Hydrocarbon Calibration Rig (HHCR). MFL is investing approximately S$20m for the building of the R&D lab, HHCR and associated facilities. A*STAR's National Metrology Centre...

2014-03-05 04:20:05

SINGAPORE, March 5, 2014 /PRNewswire/ -- Building on the fruitful past decade of UK-Singapore cooperation in scientific research and development, A*STAR's Institute of High Performance Computing (IHPC) and the Southampton Marine and Maritime Institute (SMMI) officially launched a joint laboratory in Maritime and Offshore Engineering R&D today, to develop innovative technological solutions through modelling and simulation using high performance computing technology, aimed...

2014-02-11 20:20:02

Glycomics an emerging field with implications for understanding and treating human diseasesSingapore, Feb 12, 2014 - (ACN Newswire) - A*STAR's Bioprocessing Technology Institute (BTI) today signed Memorandums of Understanding (MoUs) with Korea Basic Science Institute (KBSI) and Chungnam National University's Graduate School of Analytics Science and Technology (GRAST) to advance collaboration between Singapore and South Korea in the field of glycomics in Asia. The agreements were signed by the...

2014-02-10 04:20:11

SINGAPORE, February 10, 2014 /PRNewswire/ -- The Agency for Science, Technology and Research (A*STAR) in Singapore inked a Memorandum of Understanding (MoU) with leading aerospace company Airbus at the 3rd Aerospace Technology Leadership Forum today. The MoU signed between Airbus and A*STAR will facilitate collaboration in areas of mutual interest, including data analytics. A*STAR's extensive capabilities in data analytics solutions can be used for a wide array of...

2014-01-22 04:20:03

Source: A*STARSingapore, Jan 22, 2014 - (ACN Newswire) - Singapore's Agency for Science, Technology and Research (A*STAR) has entered into a research agreement with Nestle today to help boost the company's expansion in R&D in the country. This agreement signed by the two organisations will set the stage for cutting-edge research in areas including packaged food and beverages, food ingredients, nutrition, food manufacturing processes, food science and technology, as well as...

2013-12-05 12:20:01

This unusual discovery could aid cardiac repair and provide new therapies to common heart diseases and hypertensionSingapore, Dec 6, 2013 - (ACN Newswire) - Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids...

2013-11-21 20:23:10

SINGAPORE, November 22, 2013 /PRNewswire/ -- Industrial Additive Manufacturing Research Programme to enable direct manufacturing of high performance industrial grade components The Agency for Science, Technology and Research (A*STAR) has launched the Industrial Additive Manufacturing (AM) Programme to develop a number of critical technologies to grow an internationally competitive AM industry in support of the manufacturing sector in Singapore, particularly the...

2013-10-16 08:20:02

- Biopolis puts Singapore on the scientific world map for biomedical research- Singapore's biomedical sciences strategy achieves Economic, Scientific and Healthcare ImpactSingapore, Oct 16, 2013 - (ACN Newswire) - Singapore's Biopolis celebrates its 10th anniversary this year. Within a decade, Biopolis has established a reputation as a world-class biomedical research hub and put Singapore on the scientific world map. The Biomedical Sciences (BMS) industry has also...

2013-10-07 04:21:07

SINGAPORE and LAUSANNE, Switzerland, October 7, 2013 /PRNewswire/ -- The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group(TM) (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today...

2013-09-30 00:22:43

SINGAPORE, September 30, 2013 /PRNewswire/ -- A new Nanoimprint Foundry, led by Singapore A*STAR's Institute of Materials Research and Engineering (IMRE), will bridge the gap between laboratory-based nanotechnologies and real-world products. The pioneer initiative brings together nanotechnology suppliers and manufacturers to speed up productisation of nanoimprinting, which imbues ordinary surfaces with unique properties for sectors like consumer care, biomedical...